Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Sanity should kick in on Monday.
My prediction. A 60p share price by the end of the week....
So sbtx’s Mcap goes up 10 million today. Opti’s stake is 2.5 million of that gain but opti’s share price only goes up by 0.5 million.
Hmm.
Still very cheap.
Cenkos can’t release their research note with forecasts soon enough.
I must have been one of the last investors here to find the time to watch the presentation.
I thought it was very good. I think I asked the same questions as many others, so happy they were answered.
Things that could shift this fast.
A firm date to list on nasdaq.
Return of sbtx shares as a dividend
A commitment to profitability and revenues of 3-5 million this year.
Splitting off sweetbiotix (might be too early)
All of the above at the same time.
God I hope it’s upbeat and informative and not a rehash of old information and “we are at too early a stage to give forecasts”.
I have submitted 2 questions I hope they get answered
I’m signed up for this site already.
My question will either be when can I expect my sbtx dividend? Or now the company is maturing can you please release forward looking forecasts?
It might well be. But the reason I hold opti is for the diversification of products over several areas, it reduces the risk.
SOH seems to have a nose for early stage opportunities, maybe he will replicate sbtx with sweetbiotix or maybe something completely new from University research. Sbtx will be a bonus if it comes good.
And we still have a wildcard of a dual nasdaq listing.
Hi skid. On the day of the results one of the staff spoke to SOH and it was covered very briefly in a podcast that day. In it forecasts were mentioned. Revenues this year of between 3-5 million. Nearer the bottom if lockdown continues most of the year, but should be a million profit. Next year at least 3 million profit and the year after at least 7.
Basically a year behind where they scheduled because of the pandemic but happy to have shown growth still, and still in their view a strong buy. As I said, very brief, but still a target of over 100p, 30p of that expected to be the attributable value of sbtx to opti by the end of this year. The rest a one year out PE of 20 in still a fast growing company.
Nothing on sweetbiotix, dual listing or the reason I bought all that time ago, the in specie dividend of sbtx shares (totally agree with belgrano on that point).
I would like to see an interview as well.
So the share prophets team spoke to Stephen O’Hara.
New forecasts for the next 3 years for opti and a fair Mcap value they reckon of 90 million. Well worth a listen.
Understand the apathy to the RNS, but taking out sbtx value the market cap is 35 million and I would expect opti to be profitable this year. It should be a as recovery play, especially if sbtx increases, I think it will.
I too was surprised that h2 showed such a poor increase year on year, especially with that 6 figure sweetbiotix payment that should be accounted for. Why were royalty payments so poor?
Over to Stephen for a video update I think.
Last year opti had a operating loss of 2 million.
With the increased revenues and drop in admin it looks like this year is a million loss.
Otherwise how did they get a increase in sbtx of 7 million investment but can only report a 5.8 million profit? I assume that 1.2 million difference is the loss.
So going by the 58% increased profit margin on just over 1.5 in revenues they would have made a profit of 900k. Taking off all the other costs they were nowhere near profitability but the increased value of sbtx will save them as it probably will next year as well.
My initial thoughts are I thought Holland and Barrett would have contributed much more. I doubt much has flowed through yet from the Aussie deal, that will be this year. I expected them to be profitable and I think they needed to be nearer 3 million revenues to be there.
Are you hoping for the 5-6 times uplift in revenues again Elrico between h1 and h2?
It looks like Stephen O’Hara has really eased off on the interviews lately which is maybe a good thing, but I really don’t know what figures on revenues to hope for.
I think circa 3 million revenues for the year could see the operating loss reduced to zero as royalty payments come in h2. I think they will make a small maiden profit personally.
Taking the value of sbtx to optibiotix the market cap looks low.
I agree there haven’t been many announcements but the sweetbiotix and possible pharmaceutical applications are pretty exciting.
I can’t bring myself to sell and chase something else, I don’t know how well the Holland and Barrett deal is going over there, it sounds pretty bad with the weather and social bubbles, but my personal experience in Australia is that the optislim optibiome range are well stocked at the branches of chemist warehouse I have been to and are in prominent eye level positions. I know a few people that have been using them to lose weight after pregnancy. In my view considering the footfall at chemist warehouse and Woolworths over here this is by far the biggest deal yet but the market has barely reacted. At some point it will.
I’m looking forward to the trading update.
Flip I sold out 2 days ago I’m so lucky to dodge this bullet.
However I did just pick some up at just over 29p. I figure with cash on hand and the value of licences that’s a pretty safe bet.
We must be due for an update soon? I understand it will take longer this year because there are far more revenue streams, but has the board given any indication when it might be.